What are Regulatory Risks in Cancer Treatment and Research?
Regulatory risks in the context of cancer treatment and research refer to the potential challenges and uncertainties related to the approval, oversight, and enforcement of laws and guidelines governing cancer therapies and clinical trials. These risks can impact the development, approval, and availability of new treatments, affecting patients, healthcare providers, and pharmaceutical companies.
